A Phase 2 Trial of Cabozantinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Carcinoma in the First-Line Setting
| Autor: | Nikhil Bhat, Zakkiyya A Posey, Mark Yarchoan, Christian Michael Squillante, Sangeeta Shenoy, Raven Klein Yurtal, Marcia S. Brose, Carolyn Grande, Andrea B. Troxel, Dena M. Torrente, Anne Kathleen Harlacker |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Oncology Cancer Research medicine.medical_specialty Radiation Cabozantinib business.industry First line Thyroid carcinoma 03 medical and health sciences chemistry.chemical_compound 030104 developmental biology 0302 clinical medicine Refractory chemistry 030220 oncology & carcinogenesis Internal medicine medicine Radiology Nuclear Medicine and imaging business |
| Zdroj: | International Journal of Radiation Oncology*Biology*Physics. 100:1311 |
| ISSN: | 0360-3016 |
| DOI: | 10.1016/j.ijrobp.2017.12.028 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|